1.Molecular cloning, purification and immunogenicity of recombinant Brucella abortus 544 malate dehydrogenase protein.
Alisha Wehdnesday Bernardo REYES ; Hannah Leah Tadeja SIMBORIO ; Huynh Tan HOP ; Lauren Togonon ARAYAN ; Suk KIM
Journal of Veterinary Science 2016;17(1):119-122
The Brucella mdh gene was successfully cloned and expressed in E. coli. The purified recombinant malate dehydrogenase protein (rMDH) was reactive to Brucella-positive bovine serum in the early stage, but not reactive in the middle or late stage, and was reactive to Brucella-positive mouse serum in the late stage, but not in the early or middle stage of infection. In addition, rMDH did not react with Brucella-negative bovine or mouse sera. These results suggest that rMDH has the potential for use as a specific antigen in serological diagnosis for early detection of bovine brucellosis.
Animals
;
Antigens, Bacterial/*immunology
;
Brucella abortus/*enzymology/immunology
;
Brucellosis/diagnosis/*veterinary
;
Cattle
;
Cattle Diseases/*diagnosis
;
Cloning, Molecular
;
Enzyme-Linked Immunosorbent Assay
;
Escherichia coli/genetics
;
Malate Dehydrogenase/*genetics/*immunology/isolation & purification
;
Mice
;
Recombinant Proteins/genetics/*immunology
2.Efficacy of strain RB51 vaccine in protecting infection and vertical transmission against Brucella abortus in Sprague-Dawley rats.
Md Ariful ISLAM ; Mst Minara KHATUN ; Byeong Kirl BAEK ; Sung Il LEE
Journal of Veterinary Science 2009;10(3):211-218
Immunizing animals in the wild against Brucella (B.) abortus is essential to control bovine brucellosis because cattle can get the disease through close contact with infected wildlife. The aim of this experiment was to evaluate the effectiveness of the B. abortus strain RB51 vaccine in protecting infection as well as vertical transmission in Sprague-Dawley (SD) rats against B. abortus biotype 1. Virgin female SD rats (n = 48) two months of age were divided into two groups: one group (n = 24) received RB51 vaccine intraperitoneally with 3 x 10(10) colony forming units (CFU) and the other group (n = 24) was used as non-vaccinated control. Non-vaccinated and RB51-vaccinated rats were challenged with 1.5 x 10(9) CFU of virulent B. abortus biotype 1 six weeks after vaccination. Three weeks after challenge, all rats were bred. Verification of RB51-vaccine induced protection in SD rats was determined by bacteriological, serological and molecular screening of maternal and fetal tissues at necropsy. The RB51 vaccine elicited 81.25% protection in SD rats against infection with B. abortus biotype 1. Offspring from rats vaccinated with RB51 had a decreased (p < 0.05) prevalence of vertical transmission of B. abortus biotype 1 compared to the offspring from non-vaccinated rats (20.23% and 87.50%, respectively). This is the first report of RB51 vaccination efficacy against the vertical transmission of B. abortus in the SD rat model.
Animals
;
Antibodies, Bacterial/blood
;
Bacterial Vaccines/immunology/*standards
;
Birth Weight
;
Brucella abortus/immunology/isolation & purification/*physiology
;
Brucellosis/immunology/microbiology/*prevention & control/*transmission
;
Female
;
Infectious Disease Transmission, Vertical/*prevention & control
;
Litter Size
;
Male
;
Pregnancy
;
Pregnancy Rate
;
Rats
;
Rats, Sprague-Dawley
;
Survival Analysis
3.A Sporadic Outbreak of Human Brucellosis in Korea.
Mi Yeoun PARK ; Chang Seop LEE ; Young Sil CHOI ; Seoung Ju PARK ; Joo Sun LEE ; Heung Bum LEE
Journal of Korean Medical Science 2005;20(6):941-946
Eleven cases of human brucellosis occurred among livestock workers and a veterinarian who lived and worked in a rural area around Jeongeup City, Jeollabuk-Do, Korea from February 2003 to August 2003. Eight of the patients had taken care of Korean native cattle that were infected with bovine brucellosis and had already been slaughtered. Two of the patients had taken care of dairy cattle, and one case was a veterinarian who acquired the disease through an accidental contact with infected cattle while assisting in calf delivery. Eleven cases were identified by serologic work ups and four cases were identified via positive blood cultures. This study shows that the Republic of Korea is no longer free of human brucellosis, Brucella abortus biotype 1. We reviewed the patients' characteristics and serologic data during the oneyear follow up period, and we also discuss on the efficacy and side effects of the rifampin and doxycyline regimen used for the treatment of human brucellosis.
Adult
;
Animal Husbandry
;
Animals
;
Anti-Bacterial Agents/adverse effects/therapeutic use
;
Antibodies, Bacterial/blood
;
Base Sequence
;
Brucella abortus/genetics/immunology/isolation and purification
;
Brucellosis/drug therapy/*epidemiology/microbiology/transmission
;
Brucellosis, Bovine/transmission
;
Cattle
;
DNA, Bacterial/genetics
;
Disease Outbreaks
;
Doxycycline/adverse effects/therapeutic use
;
Female
;
Humans
;
Korea/epidemiology
;
Male
;
Middle Aged
;
Occupational Diseases/drug therapy/epidemiology/immunology/microbiology
;
Rifampin/adverse effects/therapeutic use
;
Veterinarians